ENDO USA
LIVE

Serial Number

98516417

Owner

Endo Operations Limited

Attorney

Camille M. Miller

Filing Date

Apr 24, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENDO USA Trademark

Serial Number: 98516417 • Registration: 8027143

ENDO USA is a trademark filed by Endo Operations Limited on April 24, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Endo Operations Limited

First Floor, Minerva House
Ballsbridge Dublin 4 , IE

Entity Type: 99

Trademark Details

Filing Date

April 24, 2024

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Custom manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing

Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devices, namely, surgical equipment in the fields of urology and men's health; Medical devices, namely, intrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine; medical devices for use in treating critical care, critical testing, maternal health, anesthesia, diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring, namely, arterial line, blood glucose meters, medical x-ray apparatus, electrocardiographic (ECG) recorders, Medical apparatus and instruments for treating cardiovascular disease, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters, continuous renal replacement therapy devices (CRRT), dialyzers, blood filters, filters for anesthesia, subcision devices for treating cellulite, LED light therapy devices for skin care and dermatologicial use, vocal fold medializations devices for folders, silicone gel sheeting for the treatment of scars, lasers for medical purposes, lasers for skin treatment, ultrasound apparatus for body contouring, radiofrequency therapy apparatus for cellulite reduction and body slimming

Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicines, medical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling information, namely, advice and data on the subjects of pharmaceutical preparations and medicine; Providing medical information on the subjects of aesthetic solutions to help patients feel better about their bodies; Patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient

Pharmaceutical and medical preparations in connection with critical care, critical testing, maternal health, anesthesia, malignant diseases, kidney disorders, cellulite, skin care, dermatological use, folds, scars, and body contouring and for rejuvenating the skin, and ready to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities and in doctor's offices; pharmaceutical preparations, namely, analgesics and pain management preparations, preparations for the treatment of cancers, preparations for the treatment of urological diseases and disorders, preparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, hormone replacement therapy preparations; drug substances, namely, enzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels for dermatological use and mineral supplements; food supplements; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators,vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents; pharmaceutical preparations for endocrinology, orthopedics, urology, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents

Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies

Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others; Research and development of pharmaceutical products for others

Healthcare management services, namely, providing administrative support services to physicians and healthcare providers who prescribe pharmaceutical preparations; Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 2, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 5, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2025 CRFA
ASSIGNED TO LIE
May 6, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 24, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 15, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 15, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jan 15, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 13, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 13, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 31, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2024 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jul 26, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 26, 2024 PARI
NEW APPLICATION ENTERED
Apr 24, 2024 NWAP